查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1763167

全球软骨退化治疗市场

Cartilage Degeneration Therapy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球软骨退化治疗市场规模将达 209 亿美元

全球软骨退化性变治疗市场规模预计在2024年为150亿美元，预计到2030年将达到209亿美元，2024年至2030年的复合年增长率为5.6% 。关节重建是本报告分析的细分市场之一，预计其复合年增长率为6.3%，到分析期结束时规模将达到77亿美元。软骨成形术细分市场在分析期间的复合年增长率预计为5.9%。

美国市场规模估计为 42 亿美元，中国市场预计复合年增长率为 5.4%

美国软骨退化性治疗市场规模预计在2024年达到42亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到33亿美元，在2024-2030年的分析期间内，复合年增长率为5.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为5.2%和4.7%。在欧洲，预计德国市场的复合年增长率为5.3%。

全球软骨退化性变治疗市场—主要趋势与驱动因素摘要

为什么整形外科对软骨退化治疗的需求越来越大？

由于骨关节炎、运动伤害和老龄化软骨磨损等关节疾病的盛行率不断上升，整形外科对软骨退化治疗的需求也日益增长。软骨退化会导致疼痛、活动受限和关节功能受损，是全球数百万人面临的常见疾病，尤其影响老年人口。再生医学、细胞疗法和外科手术等治疗方法因其能够恢復关节功能和减轻疼痛而日益受到关注。随着越来越多的人寻求延缓或避免关节关节重建手术的治疗，软骨再生和保存疗法正成为整形外科护理的一个重要方面。

再生医学的进步将如何改变软骨退化的治疗？

再生医学的进步正在透过提供干细胞疗法、富血小板血浆 (PRP) 和组织工程等创新解决方案，改变软骨退化治疗领域。例如，干细胞治疗方法利用间质干细胞再生受损软骨，为传统手术提供了微创的替代方案。组织工程支架和生物材料正在开发中，以支持软骨修復并刺激新组织生长。这些再生技术的进步将彻底改变软骨相关疾病的治疗格局，不仅有望解决潜在的退化问题，还能促进长期復原并改善患者预后。

人口老化加剧在软骨退化治疗市场中扮演什么角色？

人口老化是软骨退化治疗市场的主要驱动力，因为老年人更容易患骨关节炎等退化性关节疾病。随着预期寿命的延长，关节相关疾病的盛行率预计也会上升，导致对维护关节功能和改善生活品质的治疗方法需求增加。此外，年轻族群参与高强度运动和体力活动也推动了对软骨损伤治疗的需求。因此，缓解疼痛、改善活动能力并延缓关节重建手术需求的治疗方法在全球医疗保健领域日益受到重视。

软骨退化治疗市场的成长将受到多种因素的推动

软骨退化治疗市场的成长受到多种因素的推动，包括骨关节炎和运动相关损伤发病率的上升、再生医学的进步以及对微创治疗的日益关注。人口老化以及人们对非手术治疗方案的认识不断提高，推动了对恢復关节健康的创新疗法的需求。细胞疗法、组织工程和生医材料的技术进步也扩大了软骨退化患者可用的治疗选择范围。随着对有效关节保护疗法的需求日益增长，预计全球软骨退化治疗市场将显着成长。

部分

应用（膝关节、髋关节、其他）、类型（全关节重建、软骨移植、骨软骨移植、微骨折、半月软骨移植、基于细胞的软骨表面置换术、自体软骨细胞移植、其他类型）

受访公司范例

  • AlloSource
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • B. Braun SE
  • Ed. Geistlich Sohne AG（Geistlich Group）
  • Huntington Hospital
  • J&J MedTech
  • Smith & Nephew Plc
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP16255

Global Cartilage Degeneration Therapy Market to Reach US$20.9 Billion by 2030

The global market for Cartilage Degeneration Therapy estimated at US$15.0 Billion in the year 2024, is expected to reach US$20.9 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Joint Replacements, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$7.7 Billion by the end of the analysis period. Growth in the Chondroplasty segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 5.4% CAGR

The Cartilage Degeneration Therapy market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Cartilage Degeneration Therapy Market - Key Trends & Drivers Summarized

Why Is the Demand for Cartilage Degeneration Therapy Increasing in Orthopedics?

The demand for cartilage degeneration therapy is rising in orthopedics due to the increasing prevalence of joint disorders such as osteoarthritis, sports injuries, and age-related cartilage wear. Cartilage degeneration, which leads to pain, reduced mobility, and joint dysfunction, is a common issue that affects millions worldwide, especially among aging populations. Therapy options, including regenerative medicine, cell-based therapies, and surgical interventions, are gaining traction as they offer solutions to restore joint function and reduce pain. As more people seek treatments to delay or avoid joint replacement surgery, cartilage regeneration and preservation therapies are becoming a crucial aspect of orthopedic care.

How Are Advances in Regenerative Medicine Transforming Cartilage Degeneration Therapy?

Advances in regenerative medicine are transforming the field of cartilage degeneration therapy by providing innovative solutions such as stem cell therapy, platelet-rich plasma (PRP), and tissue engineering. Stem cell therapy, for example, involves the use of mesenchymal stem cells to regenerate damaged cartilage, offering a minimally invasive alternative to traditional surgery. Tissue-engineered scaffolds and biomaterials are being developed to support cartilage repair and encourage the growth of new tissue. These advancements in regenerative techniques not only address the underlying degeneration but also offer the potential to enhance long-term recovery and improve patient outcomes, making them a game-changer in the treatment of cartilage-related disorders.

What Role Does the Growing Aging Population Play in the Cartilage Degeneration Therapy Market?

The growing aging population is a significant driver of the cartilage degeneration therapy market, as elderly individuals are more prone to degenerative joint conditions such as osteoarthritis. As life expectancy increases, the prevalence of joint-related disorders is expected to rise, leading to a higher demand for therapies that can preserve joint function and improve quality of life. Additionally, younger populations engaged in high-impact sports or physical activities are also contributing to the demand for treatments that address cartilage damage. As a result, therapies that provide pain relief, improve mobility, and delay the need for joint replacement are gaining prominence in the global healthcare landscape.

The Growth in the Cartilage Degeneration Therapy Market Is Driven by Several Factors

The growth in the cartilage degeneration therapy market is driven by several factors, including the rising incidence of osteoarthritis and sports-related injuries, advancements in regenerative medicine, and the growing focus on minimally invasive treatments. The aging population, combined with the increased awareness of non-surgical treatment options, is fueling demand for innovative therapies that restore joint health. Technological advancements in cell-based therapies, tissue engineering, and biomaterials are also expanding the range of treatment options available for patients suffering from cartilage degeneration. As the need for effective joint preservation therapies increases, the cartilage degeneration therapy market is expected to experience significant growth globally.

SCOPE OF STUDY:

The report analyzes the Cartilage Degeneration Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Knee, Hip, Other Applications); Type (Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation, Other Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • AlloSource
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • B. Braun SE
  • Ed. Geistlich Sohne AG (Geistlich Group)
  • Huntington Hospital
  • J&J MedTech
  • Smith & Nephew Plc
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Cartilage Degeneration Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Osteoarthritis and Age-Related Joint Disorders
    • Growing Adoption of Regenerative Medicine for Cartilage Degeneration Treatment
    • Technological Advancements in Stem Cell and Platelet-Rich Plasma (PRP) Therapies
    • Rising Demand for Minimally Invasive Cartilage Repair Solutions
    • Expansion of Sports Medicine Driving Demand for Cartilage Restoration Therapies
    • Technological Innovations in Tissue Engineering and Cartilage Scaffolds
    • Increasing Focus on Delaying or Preventing Joint Replacement Surgeries
    • Growing Awareness of Autologous Therapies for Cartilage Repair and Regeneration
    • Rising Adoption of Biologics and Cell-Based Therapies in Orthopedic Care
    • Expansion of Research and Clinical Trials for Advanced Cartilage Degeneration Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cartilage Degeneration Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cartilage Degeneration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cartilage Degeneration Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Joint Replacements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Joint Replacements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Joint Replacements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chondroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chondroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chondroplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Osteochondral Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Osteochondral Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Osteochondral Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Microfracture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Microfracture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Microfracture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Meniscus Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Meniscus Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Meniscus Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cell based Cartilage Resurfacing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cell based Cartilage Resurfacing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cell based Cartilage Resurfacing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Autologus Chondrocyte Implantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Autologus Chondrocyte Implantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Autologus Chondrocyte Implantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Knee by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Cartilage Degeneration Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Cartilage Degeneration Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of World 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION